Ernst Lennat Westman

Capitainer AB is a company headquartered in Solna, Sweden. The firm manufactures micro-sampling devices. It was founded in 2016 by Peter Bräutigam, Niclas Roxhed and Gabriel Lenk. Christopher Aulin is currently the CEO of the company.

Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden.

HiloProbe AB engages in the development of biomarker test for accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients. It offers ColoNode. The company was founded by Sten Hammarström, Gudrun Lindmark, Marie-Louise Hammarström, Anne Israelsson and Lina Olsson in 2016 and is headquartered in Umea, Sweden.

HiloProbe AB engages in the development of biomarker test for accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients. It offers ColoNode. The company was founded by Sten Hammarström, Gudrun Lindmark, Marie-Louise Hammarström, Anne Israelsson and Lina Olsson in 2016 and is headquartered in Umea, Sweden.

Capitainer AB is a company headquartered in Solna, Sweden. The firm manufactures micro-sampling devices. It was founded in 2016 by Peter Bräutigam, Niclas Roxhed and Gabriel Lenk. Christopher Aulin is currently the CEO of the company.

Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden.

Devyser AB is a Swedish healthcare company that provides high-quality laboratory services with reliable test results. The private company is based in Hagersten, Sweden. The company uses cutting-edge technology and experienced professionals to ensure the accuracy of their results. The company's CLIA laboratory is committed to delivering trustworthy results. Devyser solutions are distributed worldwide through their specialized distributors. The CEO of the company is Fredrik Alpsten.

Devyser AB is a Swedish healthcare company that provides high-quality laboratory services with reliable test results. The private company is based in Hagersten, Sweden. The company uses cutting-edge technology and experienced professionals to ensure the accuracy of their results. The company's CLIA laboratory is committed to delivering trustworthy results. Devyser solutions are distributed worldwide through their specialized distributors. The CEO of the company is Fredrik Alpsten.

Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden.

Capitainer AB is a company headquartered in Solna, Sweden. The firm manufactures micro-sampling devices. It was founded in 2016 by Peter Bräutigam, Niclas Roxhed and Gabriel Lenk. Christopher Aulin is currently the CEO of the company.

Capitainer AB is a company headquartered in Solna, Sweden. The firm manufactures micro-sampling devices. It was founded in 2016 by Peter Bräutigam, Niclas Roxhed and Gabriel Lenk. Christopher Aulin is currently the CEO of the company.

Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden.

HiloProbe AB engages in the development of biomarker test for accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients. It offers ColoNode. The company was founded by Sten Hammarström, Gudrun Lindmark, Marie-Louise Hammarström, Anne Israelsson and Lina Olsson in 2016 and is headquartered in Umea, Sweden.

HiloProbe AB engages in the development of biomarker test for accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients. It offers ColoNode. The company was founded by Sten Hammarström, Gudrun Lindmark, Marie-Louise Hammarström, Anne Israelsson and Lina Olsson in 2016 and is headquartered in Umea, Sweden.